Covid-19 roundup: As­traZeneca cuts Q1 vac­cine sup­ply to EU by a third — re­port; Sanofi, Trans­late ush­er an­oth­er mR­NA shot in­to clin­ic

Ten­sions be­tween As­traZeneca and the EU are far from set­tling, as the phar­ma re­port­ed­ly plans to cut sup­ply of its Ox­ford-part­nered vac­cine to the bloc by about a third in the first quar­ter.

Ac­cord­ing to doc­u­ments re­viewed by Reuters, As­traZeneca now plans to de­liv­er about 30 mil­lion dos­es to the EU by the end of March, as op­posed to the 90 mil­lion ini­tial­ly promised in its con­tract. An­oth­er 20 mil­lion dos­es are now set to come in April, Reuters re­port­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.